Cellular and biophysical evidence for interactions between adenosine triphosphate and P-glycoprotein substrates: functional implications for adenosine triphosphate/drug cotransport in P-glycoprotein overexpressing tumor cells and in P-glycoprotein low-level expressing erythrocytes

被引:19
作者
Abraham, EH [1 ]
Shrivastav, B
Salikhova, AY
Sterling, KM
Johnston, N
Guidotti, G
Scala, S
Litman, T
Chan, KC
Arceci, RJ
Steiglitz, K
Herscher, L
Okunieff, P
机构
[1] Dartmouth Med Sch, Dept Med, Hanover, NH 03755 USA
[2] NCI, Div Clin Sci, Radiat Oncol Branch, Bethesda, MD 20892 USA
[3] NCI, Div Clin Sci, Radiat Oncol Branch, Bethesda, MD 20892 USA
[4] Harvard Univ, Dept Biochem & Mol Biol, Cambridge, MA 02138 USA
[5] NCI, Div Clin Sci, Bethesda, MD 20892 USA
[6] NCI, Analyt Chem Lab, SAIC Frederick, Frederick, MD 21702 USA
[7] Harvard Univ, Sch Med, Dana Farber Canc Ctr, Boston, MA 02115 USA
[8] Univ Rochester, Ctr Canc, Dept Radiat Oncol, Rochester, NY 14642 USA
关键词
erythrocyte; RBC; ATP (adenosine triphosphate); MDR (multidrug resistance protein); Pgp (P-glycoprotein); CD39; apyrase; ATP transporter; cotransport; plasma ATP; Pgp drug substrates; doxorubicin; adriamycin; verapamil; colchicine; electrophoresis; capillary electrophoresis; knockout mice; Taxol; camptothecin; stoichiometry of coupling; ABC proteins;
D O I
10.1006/bcmd.2000.0373
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P-glycoprotein is involved with the removal of drugs, most of them cations, from the plasma membrane and cytoplasm. Pgp is also associated with movement of ATP, an anion, from the cytoplasm to the extracellular space. The central question of this study is whether drug and ATP transport associated with the expression of Pgp are in any way coupled. We have measured the stoichiometry of transport coupling between drug and ATP release. The drug and ATP transport that is inhibitable by the sulfonylurea compound, glyburide (P. E. Golstein, A. Boom, J. van Geffel, P. Jacobs, B. Masereel, and R. Beauwens, Pfluger's Arch. 437, 652, 1999), permits determination of the transport coupling ratio, which is close to 1:1. In view of this result, we asked whether ATP interacts directly with Pgp substrates. We show by measuring the movement of Pgp substrates in electric fields that ATP and drug movement are coupled. The results are compatible with the view that substrates for Pgp efflux are driven by the movement of ATP through electrostatic interaction and effective ATP-drug complex formation with net anionic character. This mechanism not only pertains to drug efflux from tumor cells overexpressing Pgp, but also provides a framework for understanding the role of erythrocytes in drug resistance. The erythrocyte consists of a membrane surrounding a millimolar pool of ATP. Mammalian RBCs have no nucleus or DNA drug/toxin targets. From the perspective of drug/ATP complex formation, the RBC serves as an important electrochemical sink for toxins. The presence in the erythrocyte membrane of approximately 100 Pgp copies per RBC provides a mechanism for eventual toxin clearance. The RBC transport of toxins permits their removal from sensitive structures and ultimate clearance from the organism via the liver and/or kidneys. (C) 2001 Academic Press.
引用
收藏
页码:181 / 200
页数:20
相关论文
共 70 条
  • [11] CANTIELLO HF, 1994, J BIOL CHEM, V269, P11224
  • [12] Electrodiffusional ATP movement through the cystic fibrosis transmembrane conductance regulator
    Cantiello, HF
    Jackson, GR
    Grosman, CF
    Prat, AG
    Borkan, SC
    Wang, YH
    Reisin, IL
    O'Riordan, CR
    Ausiello, D
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1998, 274 (03): : C799 - C809
  • [13] Nucleotide transport through the cystic fibrosis transmembrane conductance regulator
    Cantiello, HF
    [J]. BIOSCIENCE REPORTS, 1997, 17 (02) : 147 - 171
  • [14] Association and stoichiometry of K-ATP channel subunits
    Clement, JP
    Kunjilwar, K
    Gonzalez, G
    Schwanstecher, M
    Panten, U
    AguilarBryan, L
    Bryan, J
    [J]. NEURON, 1997, 18 (05) : 827 - 838
  • [15] DALMARK M, 1982, MOL PHARMACOL, V22, P158
  • [16] DALMARK M, 1983, SCAND J CLIN LAB INV, V43, P241
  • [17] Transbilayer movement of NBD-labeled phospholipids in red blood cell membranes: Outward-directed transport by the multidrug resistance protein 1 (MRP1)
    Dekkers, DWC
    Comfurius, P
    Schroit, AJ
    Bevers, EM
    Zwaal, RFA
    [J]. BIOCHEMISTRY, 1998, 37 (42) : 14833 - 14837
  • [18] DOIGE CA, 1992, BIOCHIM BIOPHYS ACTA, V1109, P161, DOI 10.1016/0005-2736(92)90079-2
  • [19] Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation
    Enjyoji, K
    Sévigny, J
    Lin, Y
    Frenette, PS
    Christie, PD
    Esch, JSA
    Imai, M
    Edelberg, JM
    Rayburn, H
    Lech, M
    Beeler, DL
    Csizmadia, E
    Wagner, DD
    Robson, SC
    Rosenberg, RD
    [J]. NATURE MEDICINE, 1999, 5 (09) : 1010 - 1017
  • [20] Mechanism of action of p-glycoprotein in relation to passive membrane permeation
    Eytan, GD
    Kuchel, PW
    [J]. INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 190, 1999, 190 : 175 - 250